Protein Intake Dosage on the Prognosis of Neurocritical Patients
NCT07295301 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 216
Last updated 2025-12-19
Summary
This study investigates the effect of different early protein supplementation levels (1.0-2.0g/kg/d, divided into three groups) on the prognosis of neurocritical patients, focusing on the 28-day Glasgow Coma Scale (GCS) score improvement rate. Participants will be randomly assigned to receive varying protein doses, and their short-term (28-day mortality, ICU stay, complications) and long-term (90-day mortality, readmission rate) clinical outcomes will also be compared.
Conditions
- Neurocritical Conditions
- Traumatic Brain Injury
- Ischemic Stroke
Interventions
- DIETARY_SUPPLEMENT
-
Low-Dose Enteral Protein Supplementation (Enteral Nutrition Formulas + Whey Protein Powder)
This intervention provides enteral protein supplementation for neurocritical patients in the ICU, using enteral nutrition formulas (in powder or emulsion form). When the protein dosage of the enteral nutrition formula is insufficient, whey protein powder is added; intravenous amino acids are used as an alternative only when patients refuse whey protein powder supplementation. The intervention is initiated within 48 hours of ICU admission, with the protein dosage adjusted gradually: 0.2-0.8 g/kg/d from day 1 to day 4, 0.8-1.0 g/kg/d from day 5 to day 7, and then maintained at 1.0-1.2 g/kg/d from day 8 to day 14. It is administered daily via oral intake or tube feeding.
- DIETARY_SUPPLEMENT
-
Moderate-Dose Enteral Protein Supplementation (Enteral Nutrition Formulas + Whey Protein Powder)
Enteral protein supplementation for neurocritical patients in the ICU, using enteral nutrition formulas (including powders or emulsions). Whey protein powder is added when the protein dosage of the enteral nutrition formula is insufficient. Initiated within 48 hours of ICU admission, with dosage adjusted gradually: 0.2-0.8 g/kg/d from day 1 to day 4, 0.8-1.0 g/kg/d from day 5 to day 7, and then maintained at 1.3-1.5 g/kg/d from day 8 to day 14. Administered via oral intake or tube feeding, daily.
- DIETARY_SUPPLEMENT
-
High-Dose Enteral Protein Supplementation (Enteral Nutrition Formulas + Whey Protein Powder)
Enteral protein supplementation for neurocritical patients in the ICU, using enteral nutrition formulas (including powders or emulsions). Whey protein powder is added when the protein dosage of the enteral nutrition formula is insufficient. Initiated within 48 hours of ICU admission, with dosage adjusted gradually: 0.2-0.8 g/kg/d from day 1 to day 4, 0.8-1.0 g/kg/d from day 5 to day 7, and then maintained at above 1.6 g/kg/d from day 8 to day 14. Administered via oral intake or tube feeding, daily.
Sponsors & Collaborators
-
Wenshan City People's Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-12-31
- Primary Completion
- 2028-06-30
- Completion
- 2028-10-31
More Related Trials
-
Comparing High-protein Vs. Standard Protein Nutritional Support in Critically Ill Patients At Risk for Refeeding Syndrome
NCT06825377 ·Status: RECRUITING ·Phase: NA
-
Study in ICU Patients Regarding Protein Intake and CT-derived Body Composition
NCT02817646 ·Status: COMPLETED
-
The Basel Enteral High Protein Study
NCT02678325 ·Status: TERMINATED ·Phase: NA
-
Enhanced Protein Intake to Support Muscle Protein Synthesis in ICU
NCT06714240 ·Status: RECRUITING ·Phase: NA
-
Relationship Between Protein Intake and ICU Skeletal Muscle Weakness
NCT06012201 ·Status: UNKNOWN
-
High Protein Intake in Critically Ill Ventilated Patients
NCT04977440 ·Status: COMPLETED
-
Effects of Parenteral Protein Concentrations in Critically Ill Patients
NCT04961866 ·Status: COMPLETED ·Phase: NA
-
The PREServation of MUScle Function in Critically Ill Patients (PRESMUS)
NCT03231540 ·Status: UNKNOWN ·Phase: NA
-
Observational Study on Energy Expenditure and Protein Metabolism Changes in Patients With Severe Brain Injury.
NCT06577402 ·Status: RECRUITING
-
High Protein Intake and Early Exercise in Adult Intensive Care Patients
NCT03469882 ·Status: COMPLETED ·Phase: NA
-
Replacing Protein Via Enteral Nutrition in a Stepwise Approach in Critically Ill Patients
NCT03480555 ·Status: COMPLETED ·Phase: NA
-
Time to Protein Target Using a High Whey Protein Enteral Nutrition in Critically Ill Patients
NCT02815527 ·Status: COMPLETED
-
Impact of NMES and HPRO on Recovery After SAH- Pilot Study
NCT03201094 ·Status: RECRUITING ·Phase: NA
-
Supplemental Enteral Protein in Critical Illness
NCT03170401 ·Status: COMPLETED ·Phase: PHASE3
-
Protein-bound Versus Free Amino Acid Nutrition During INtestinal Malabsorption in Critical Illness
NCT04791774 ·Status: COMPLETED ·Phase: NA
-
Early and Adequate Protein Feeding Post-Traumatic Injury
NCT02837861 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Safety and Efficacy of an Amino Acid Blend on Muscle and Gut Functionality in ICU Patients
NCT02968836 ·Status: COMPLETED ·Phase: NA
-
Assessing The Effects of Exercise, Protein, and Electric Stimulation On Intensive Care Unit Patients Outcomes
NCT02509520 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effect of Enteral Nutrition Enriched in Protein and Based on Indirect Calorimetry Measurement in Chronically Critically Ill Patients
NCT01142570 ·Status: UNKNOWN ·Phase: NA
-
Protein Intake Plus Neuromuscular Electrical Stimulation on Muscle Mass in Hospitalized Elderly
NCT05008705 ·Status: RECRUITING ·Phase: NA
-
Replacing Protein Via Enteral Nutrition in Critically Ill Patients
NCT04475666 ·Status: RECRUITING ·Phase: NA
-
Optimized Caloric-proteic Nutrition in Critically Ill Patients
NCT03060668 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Administration of High Levels of Protein to Critically Ill Patients.
NCT05918757 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study About Nutritional Support of Enhanced Protein in Critical Patients
NCT04177446 ·Status: UNKNOWN ·Phase: NA
-
Meeting Protein Targets in Critically Ill Patients
NCT03319836 ·Status: COMPLETED